Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00478166 · ClinicalTrials.gov registry record

Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease

A clinical trial of Dementia and Alzheimers Disease, sponsored by University of Wisconsin, Madison.

Completed
Registry status
206
Enrollment target
1
Study location

NCT00478166: Completed study of Dementia and Alzheimers Disease, sponsored by University of Wisconsin, Madison.

NCT00478166 is a study of Dementia and Alzheimers Disease that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 206 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00478166, a study of Dementia and Alzheimers Disease, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
206 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to use fMRI techniques to explore a certain part of the brain associated with Alzheimer's disease known as the posterior cingulate. Determining the functionality of this brain region may help us diagnose AD more accurately, thus allowing earlier treatment.

Study Locations (1)

Wisconsin

  • University of Wisconsin - Wisconsin Comprehensive Memory Program - Madison

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2005-07
Est. Completion 2007-10
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00478166 record still lists

NCT00478166 is an observational study that tracks outcomes without assigning an intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower).

The record links to 5 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.

NCT00478166 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00478166 about?

NCT00478166 is a clinical study titled "Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease". The purpose of this study is to use fMRI techniques to explore a certain part of the brain associated with Alzheimer's disease known as the posterior cingulate. Determining the functionality of this brain region may help us diagnose AD more accurately, thus allowing earlier treatment.

What is the current status of trial NCT00478166?

This trial is currently completed. The enrollment target is 206 participants. The study started on 2005-07. Estimated completion is 2007-10.

What conditions does trial NCT00478166 study?

This clinical trial studies the following conditions: Dementia, Alzheimers Disease, Magnetic Resonance Imaging, Adult Children, Risk.

Who is sponsoring clinical trial NCT00478166?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00478166 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00478166's enrollment target sits among peer trials

206 88th of 199 higher than 112 of 199 other Dementia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03373968 · 206 participants · Phase 2

    Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  • NCT03550391 · 206 participants · Phase 3

    Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • NCT04757116 · 206 participants · NA

    Post-Market Study to Assess iTind Safety in Comparison to UroLift

  • NCT05675865 · 206 participants · NA

    Cryoablation for Monomorphic Ventricular Tachycardia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00478166, the US trial registry maintained by the National Library of Medicine. NCT00478166 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.